A Stanford geneticist is leveraging Co-Scientist to accelerate the discovery of new treatments for chronic liver disease. This AI-powered platform analyzes vast biological datasets, enabling researchers to identify promising repurposed drugs and understand complex disease mechanisms more efficiently. The work aims to offer new therapeutic avenues for patients suffering from liver fibrosis.
Opening Kapyn…